Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2008 / Cilt: 17 - Sayı: 1

Retrospective analysis of the cases diagnosed with rapidly progressive glomerulonephitis

Hızlı ilerleyen glomerülonefrit tanısı konulan olguların retrospektif analizi

Pages
10–15
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients who have severe renal failure (serum creatinine level ³5 mg/dl) at diagnosis, prognosis of crescentic glomerulonephritis is poor and the development of ESRD is common, although treatment is given.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In the present study, we investigated clinical and histopathological findings, treatment, and course of patients with crescentic glomerulonephritis in our center.
📊
Key Findings & Data:Patients and Methods: 35 patients who were diagnosed with crescentic glomerulonephritis by renal biopsy were retrospectively investigated.
💡
Conclusion & Impact:In patients who have severe renal failure (serum creatinine level ³5 mg/dl) at diagnosis, prognosis of crescentic glomerulonephritis is poor and the development of ESRD is common, although treatment is given.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In the present study, we investigated clinical and histopathological findings, treatment, and course of patients with crescentic glomerulonephritis in our center. Patients and Methods: 35 patients who were diagnosed with crescentic glomerulonephritis by renal biopsy were retrospectively investigated. Results: 25 (71.4%) of the patients were male and mean age was 34.43 ± 15.7 years. All of 13 patients had serum creatinine level ³ 5 mg/dl and 7 of 18 patients who had serum creatinine level < 5 mg/dl did not respond to treatment and developed end stage renal disease (ESRD). The crescentic glomerular change percentage was significantly higher in patients who did not respond to treatment and developed ESRD than those who respond to treatment (79.04 ± 21.57 vs. 52.21 ± 20.63, p = 0.002). There was a significant positive correlation between the crescentic glomerular change percentage and serum creatinine level. Conclusion: In crescentic glomerulonephritis, there is a significant correlation between histopathological findings and renal function. In patients who have severe renal failure (serum creatinine level ³5 mg/dl) at diagnosis, prognosis of crescentic glomerulonephritis is poor and the development of ESRD is common, although treatment is given.

Özet

Amaç:Bu çalışmada merkezimizde takip edilen kresentik glomerülonefritli hastaların klinik ve histopatolojik bulgularını, tedavilerini ve seyirlerini inceledik. Hastalar ve Yöntem: Böbrek biyopsisi yapılmak suretiyle kresentik glomerülonefrit tanısı konulan 35 hasta retrospektif olarak incelendi. Bulgular: Hastaların 25’i (%71.4) erkekti ve ortalama yaş 34.43 ± 15.7 idi. Serum kreatinin düzeyi 5 mg/dl veya daha yüksek olan 13 hastanın hiçbiri tedaviye yanıt vermedi ve son dönem böbrek yetmezliği (SDBY) gelişti. Serum kreatinin düzeyi 5 mg/dl’nin altında olan 18 hastanın ise yedisinde SDBY gelişti. Histopatolojik incelemede kresent görünümü yüzdesi SDBY gelişen hastalarda, gelişmeyenlerden anlamlı olarak yüksekti (sırasıyla 79.04 ± 21.57’ye karşı 52.21 ± 20.63, p = 0.002). Kresent görünümü yüzdesi ile serum kreatinin düzeyleri arasında belirgin pozitif korelasyon saptandı. Sonuç: Kresentik glomerülonefritte histolojik bulgularla böbrek fonksiyonları arasında belirgin bir ilişki vardır. Tanı anında ciddi böbrek yetmezliği (serum kreatinin düzeyi 5 mg/dl veya daha yüksek) olan hastalarda, kresentik glomerülonefrit tedaviye rağmen kötü gidişlidir

🔖

Cite This Article

UTAŞ, C., AKGÜN, H., TOKGÖZ, B., OYMAK, O., SİPAHİOĞLU, M. H., AKÇAKAYA, M., ÜNAL, A. (2022). Retrospective analysis of the cases diagnosed with rapidly progressive glomerulonephitis. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 17 - Sayı: 1, 10–15. https://ajindex.com/articles/636520

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988;11:449-464
  2. McLeish KR, Yum MN, Luft FC. Rapidly progressive glomerulonephritis in adults: clinical and histologic correlations. Clin Nephrol 1978;10:43-50
  3. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003;63:1164-1177
  4. Gupta RK. Pauci-immune crescentic glomerulonephritis. Indian J Pathol Microbiol 2003;46:357-366
  5. Savage CO. ANCA-associated renal vasculitis. Kidney Int 2001;60:1614-1627
  6. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-1523
  7. Franssen CF, Stegeman CA, Kallenberg CG, et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 2000;57:2195-2206
  8. Langford CA, Balow JE. New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney. Curr Opin Nephrol Hypertens 2003;12:267-272
  9. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001;13:48-55
  10. Wiggins RC, Kershaw DB. Crescentic glomerulonephritis. In: Massry SG, Glassock RJ (eds), Textbook of Nephrology. Lippincott Williams & Wilkins, Philadelphia 2001, pp 720-725
  11. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32
  12. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033-1042.